Lincoln Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$526K Sell
5,737
-1,759
-23% -$154K 0.09% 91
2026
Q1
$639K Sell
7,496
-490
-6% -$43.7K 0.12% 79
2025
Q4
$631K Sell
7,986
-202
-2% -$15.8K 0.11% 84
2025
Q3
$639K Sell
8,188
-1,349
-14% -$115K 0.12% 84
2025
Q2
$867K Sell
9,537
-89
-0.9% -$8.13K 0.17% 66
2025
Q1
$922K Sell
9,626
-61
-0.6% -$5.46K 0.19% 62
2024
Q4
$881K Hold
9,687
0.19% 58
2024
Q3
$1.01M Hold
9,687
0.21% 55
2024
Q2
$940K Sell
9,687
-390
-4% -$36K 0.21% 55
2024
Q1
$907K Hold
10,077
0.2% 57
2023
Q4
$803K Hold
10,077
0.2% 57
2023
Q3
$717K Buy
10,077
+100
+1% +$7.48K 0.19% 57
2023
Q2
$769K Hold
9,977
0.2% 57
2023
Q1
$750K Sell
9,977
-102
-1% -$7.58K 0.21% 60
2022
Q4
$794K Hold
10,079
0.23% 59
2022
Q3
$708K Hold
10,079
0.22% 58
2022
Q2
$808K Hold
10,079
0.23% 54
2022
Q1
$764K Hold
10,079
0.18% 61
2021
Q4
$860K Sell
10,079
-650
-6% -$50.8K 0.21% 52
2021
Q3
$811K Sell
10,729
-165
-2% -$13.1K 0.22% 51
2021
Q2
$886K Hold
10,894
0.25% 47
2021
Q1
$859K Hold
10,894
0.27% 44
2020
Q4
$932K Hold
10,894
0.3% 40
2020
Q3
$840K Sell
10,894
-90
-0.8% -$6.86K 0.31% 42
2020
Q2
$805K Hold
10,984
0.34% 44
2020
Q1
$729K Hold
10,984
0.37% 44
2019
Q4
$756K Hold
10,984
0.31% 40
2019
Q3
$807K Hold
10,984
0.36% 38
2019
Q2
$787K Sell
10,984
-80
-0.7% -$5.68K 0.35% 34
2019
Q1
$758K Sell
11,064
-46
-0.4% -$2.97K 0.37% 35
2018
Q4
$661K Buy
11,110
+76
+0.7% +$4.75K 0.36% 33
2018
Q3
$739K Hold
11,034
0.37% 34
2018
Q2
$717K Sell
11,034
-100
-0.9% -$6.54K 0.38% 33
2018
Q1
$798K Sell
11,134
-436
-4% -$31.4K 0.43% 34
2017
Q4
$873K Hold
11,570
0.49% 34
2017
Q3
$843K Sell
11,570
-300
-3% -$21.6K 0.52% 34
2017
Q2
$880K Buy
11,870
+389
+3% +$28.9K 0.55% 33
2017
Q1
$840K Buy
11,481
+408
+4% +$28.6K 0.57% 33
2016
Q4
$725K Buy
11,073
+223
+2% +$15.3K 0.52% 33
2016
Q3
$804K Sell
10,850
-80
-0.7% -$5.91K 0.59% 31
2016
Q2
$800K Sell
10,930
-85
-0.8% -$6.05K 0.6% 31
2016
Q1
$778K Buy
11,015
+440
+4% +$29.3K 0.58% 33
2015
Q4
$705K Hold
10,575
0.56% 32
2015
Q3
$671K Sell
10,575
-106
-1% -$6.92K 0.56% 33
2015
Q2
$699K Hold
10,681
0.59% 31
2015
Q1
$741K Sell
10,681
-10
-0.1% -$691 0.64% 31
2014
Q4
$740K Buy
+10,691
New +$722K 0.64% 32

Other funds holding CL

Lincoln Capital's CL Position: Q2 2026 in Review

Lincoln Capital reduced its Colgate-Palmolive (CL) stake by 23% in Q2 2026, selling an estimated $154K and leaving 5,737 shares worth $526K. The position accounts for 0.09% of the portfolio, ranked #91.

Lincoln Capital first reported a position in CL in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.01M in Q3 2024. 621 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Lincoln Capital held 5,737 shares of Colgate-Palmolive worth $526K as of Q2 2026.
  • Lincoln Capital sold 1,759 Colgate-Palmolive shares in Q2 2026, an estimated $154K.
  • Colgate-Palmolive made up 0.09% of Lincoln Capital's portfolio in Q2 2026, its #91 holding.
  • Lincoln Capital first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 47 quarters since.
  • Lincoln Capital's Colgate-Palmolive position peaked at $1.01M in Q3 2024.
  • 621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.